This HTML5 document contains 37 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/drugbank/drug/DB04017/identifier/pdb/
n13http://linked.opendata.cz/resource/drugbank/drug/DB04017/identifier/bindingdb/
n8http://linked.opendata.cz/resource/drugbank/drug/DB04017/identifier/pubchem-compound/
n6http://bio2rdf.org/drugbank:
n9http://linked.opendata.cz/resource/drugbank/drug/DB04017/identifier/pubchem-substance/
admshttp://www.w3.org/ns/adms#
n10http://linked.opendata.cz/resource/drugbank/drug/DB04017/identifier/drugbank/
n15http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n14http://linked.opendata.cz/resource/drugbank/drug/DB04017/identifier/chemspider/

Statements

Subject Item
n2:DB04017
rdf:type
n3:Drug
n3:description
An antidepressive agent and monoamine oxidase inhibitor related to PARGYLINE. [PubChem]
n3:group
experimental
owl:sameAs
n6:DB04017 n15:DB04017
dcterms:title
N-Methyl-N-Propargyl-3-(2,4-Dichlorophenoxy)Propylamine
adms:identifier
n8:4380 n9:46507410 n10:DB04017 n11:MLG n13:15581 n14:4227
n3:IUPAC-Name
n4:271B5922-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B5928-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5927-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5924-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5925-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5926-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5920-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B591E-363D-11E5-9242-09173F13E4C5 n4:271B5921-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B591F-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B592E-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B592F-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B5929-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B592A-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B592C-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B592B-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B592D-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B5933-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5935-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5936-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5932-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5931-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5934-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5923-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5930-363D-11E5-9242-09173F13E4C5